BDBM50383380 CHEMBL2030553::CHEMBL2070047::US10544104, Compound 28::US11247972, Compound 28::US9765037, Compound 28

SMILES COc1ccc2cc(ccc2c1)-c1nn(CC2CCNCC2)c2ncnc(N)c12

InChI Key InChIKey=MBHHJCMRPHUOAD-UHFFFAOYSA-N

Data  2 KI  19 IC50

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 21 hits for monomerid = 50383380   

TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
University of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.30nMAssay Description:Two types of enzyme assays were developed to follow TgCDPK1 activity, a radiometric scintillation proximity assay measured the labeled γ-phospha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalcium/calmodulin dependent protein kinase with a kinas domain and 4 calmodulin-like EF hands(Cryptosporidium parvum (strain Iowa II))
University of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.30nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetcGMP-dependent protein kinase(Toxoplasma gondii)
University of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase HCK(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL1(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalmodulin-domain protein kinase 1, putative(Cryptosporidium parvum (strain Iowa II))
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.30nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetTyrosine-protein kinase HCK(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL1(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 4.90nMAssay Description:Most known kinase inhibitors bind in the ATP-binding pocket of the active site19,20. These inhibitors exploit many of the same hydrophobic contacts a...More data for this Ligand-Target Pair
In DepthDetails
US Patent
PDB3D3D Structure (crystal)
TargetTyrosine-protein kinase ABL1(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ABL using EAIYAAPFAKKK-OH as substrate by phosphor imaging methodMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
University of Washington

Curated by ChEMBL
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human EGFR using poly glu-Tyr as substrate after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase CSK(Human)
University of Washington

Curated by ChEMBL
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEphrin type-A receptor 3(Human)
University of Washington

Curated by ChEMBL
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human EPHA3 using myelin basic protein as substrate after 120 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMitogen-activated protein kinase 14(Human)
University of Washington

Curated by ChEMBL
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human p38alpha using myelin basic protein as substrate after 180 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase Lck(Human)
University of Washington

Curated by ChEMBL
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 620nMAssay Description:Inhibition of human LCK using Ac-EIYGEFKKK-OH as substrate after 60 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphor imaging methodMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataKi: >1.50E+4nMAssay Description:Inhibition of human ABL by radiometric assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
University of Washington Through Its Center For

US Patent
LigandPNGBDBM50383380(CHEMBL2030553 | CHEMBL2070047 | US9765037, Compoun...)
Affinity DataKi: >2.00E+4nMAssay Description:Inhibition of human SRC by radiometric assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed